DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-1.5%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.63B
AUM Growth
+$5.63B
(+18%)
Cap. Flow
+$590M
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
32.98%
Holding
167
New
29
Increased
30
Reduced
12
Closed
23
Top Buys
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$250M |
| 2 |
AdaptHealth
AHCO
|
$139M |
| 3 |
CMAX
CareMax, Inc. Class A Common Stock
CMAX
|
$129M |
| 4 |
Organogenesis Holdings
ORGO
|
$70.2M |
| 5 |
QuidelOrtho
QDEL
|
$52.4M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$110M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$88.6M |
| 3 |
Biogen
BIIB
|
$86.7M |
| 4 |
Centene
CNC
|
$72.2M |
| 5 |
The Oncology Institute
TOI
|
$54.3M |
Sector Composition
| 1 | Healthcare | 68.23% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $269M | 4.78% | 18,824,000 +1,600,000 | +9% | +$22.9M |
|
|
OMIC
2
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $250M | 4.45% | +9,112,019 | New | +$250M |
|
|
CMAX
3
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $216M | 3.84% | 16,778,750 +10,000,000 | +148% | +$129M |
|
|
4
AdaptHealth
AHCO
$1.28B
| $202M | 3.58% | 7,353,792 +5,075,921 | +223% | +$139M |
|
|
5
Organogenesis Holdings
ORGO
$653M
| $120M | 2.13% | 7,222,127 +4,226,489 | +141% | +$70.2M |
|
6
Edgewise Therapeutics
EWTX
$1.51B
| $83.9M | 1.49% | 3,933,137 | – | – |
|
7
Pulmonx
LUNG
$69.7M
| $79.5M | 1.41% | 1,800,887 +863,855 | +92% | +$38.1M |
|
|
AFIB
8
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $73.7M | 1.31% | 4,341,799 | – | – |
|
|
9
Centene
CNC
$14.3B
| $72.6M | 1.29% | 995,000 -990,619 | -50% | -$72.2M |
|
10
Neurocrine Biosciences
NBIX
$13.8B
| $70.6M | 1.25% | 725,000 | – | – |
|
11
Pacira BioSciences
PCRX
$1.2B
| $69.6M | 1.24% | 1,147,000 -17,973 | -2% | -$1.09M |
|
12
Protagonist Therapeutics
PTGX
$3.67B
| $61.2M | 1.09% | 1,362,790 +104,000 | +8% | +$4.67M |
|
13
Mirum Pharmaceuticals
MIRM
$3.71B
| $59.6M | 1.06% | 3,448,912 | – | – |
|
14
Molina Healthcare
MOH
$9.8B
| $58.7M | 1.04% | 231,776 | – | – |
|
15
Larimar Therapeutics
LRMR
$310M
| $57.3M | 1.02% | 5,830,249 +685,710 | +13% | +$6.73M |
|
|
SILK
16
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $54.5M | 0.97% | 1,138,525 +649,980 | +133% | +$31.1M |
|
17
Zimmer Biomet
ZBH
$21B
| $54.4M | 0.97% | 338,000 -19,000 | -5% | -$3.06M |
|
|
CNST
18
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $54.1M | 0.96% | 1,601,427 -107,530 | -6% | -$3.63M |
|
|
19
QuidelOrtho
QDEL
$1.95B
| $52.4M | 0.93% | +409,219 | New | +$52.4M |
|
20
Alphatec Holdings
ATEC
$2.35B
| $52.1M | 0.93% | 3,402,384 +200,468 | +6% | +$3.07M |
|
21
KalVista Pharmaceuticals
KALV
$678M
| $51.8M | 0.92% | 2,163,554 +1,143,549 | +112% | +$27.4M |
|
|
22
The Oncology Institute
TOI
$318M
| $49.8M | 0.88% | 5,000,000 -5,460,000 | -52% | -$54.3M |
|
23
Revolution Medicines
RVMD
$7.1B
| $49.7M | 0.88% | 1,565,712 +129,000 | +9% | +$4.09M |
|
|
DCPH
24
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $49.2M | 0.87% | 1,343,560 +814,975 | +154% | +$29.8M |
|
|
SWTX
25
DELISTED
SpringWorks Therapeutics
SWTX
| $46M | 0.82% | 558,574 | – | – |
|